“Breaking News: Akero Therapeutics Successfully Completes Upsized Public Offering and Fully Exercises Underwriters’ Option to Purchase Additional Shares”

Akero Therapeutics, Inc. Announces Successful Completion of Public Offering New Opportunities for Innovation Akero Therapeutics, Inc., a leading clinical-stage company focused on developing revolutionary treatments for patients with severe metabolic conditions, has proudly announced the closure of its recent underwritten public offering. This initiative has seen the company issue 6,427,170 shares of common stock at…

Read More

“Breaking News: Financial Institutions Inc. Crushes Fourth Quarter and Full Year 2024 – Here’s the Scoop!”

A New Year, A New Financial Report Financial Institutions, Inc. Reports Fourth Quarter and Year-End Results Well, folks, it’s that time of year again – time for Financial Institutions, Inc. to release their financial and operational results for the fourth quarter and year ended December 31, 2024. The parent company of Five Star Bank and…

Read More

“Breaking News: Fannie Mae’s December 2024 Monthly Summary Released!”

Fannie Mae’s December 2024 Monthly Summary Report Introduction WASHINGTON, Jan. 30, 2025 /PRNewswire/ — Fannie Mae’s (OTCQB: FNMA) December 2024 Monthly Summary is now available. The monthly summary report contains information about Fannie Mae’s monthly and year-to-date activities for our gross mortgage portfolio, mortgage-backed securities and other guarantees, interest rate risk measures, and serious delinquency…

Read More

“Meet the Newest Addition to Our Board: Dipal Doshi Brings Fresh Perspective and Plenty of Dad Jokes to Azenta!”

Welcome to the Board, Dipal Doshi! A New Addition to the Azenta, Inc. Family BURLINGTON, Mass. , Jan. 30, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) made a big announcement today at its Annual Meeting of Stockholders – the addition of Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA), to its Board of…

Read More